
Mirabegron (25mg)
Active composition
Medical applications
The MSN Mirabig Tablet ER, containing 25mg of Mirabegron, is an extended-release oral medication primarily indicated for the treatment of overactive bladder with symptoms such as urge urinary incontinence, urgency, and frequency in adults. It works by relaxing the bladder muscles, thereby increasing the bladder capacity and reducing the urgency to urinate. The tablet's extended-release formulation allows for once-daily dosing, improving patient compliance. It should be taken orally once daily with or without food. Dosage adjustments may be necessary for patients with moderate or severe hepatic impairment. Common adverse effects include hypertension, headache, and urinary tract infection. Consult a healthcare provider for more detailed information about its use, potential interactions, and safety precautions.
Anilide Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
MSN Mirabig Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
MSN Mirabig Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
MSN Mirabig Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of MSN Mirabig Tablet ER may be needed. Please consult your doctor.
Exercise Caution
MSN Mirabig Tablet ER does not usually affect your ability to drive.
Consult Doctor
MSN Mirabig Tablet ER should be used with caution in patients with liver disease. Dose adjustment of MSN Mirabig Tablet ER may be needed. Please consult your doctor. Use of MSN Mirabig Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for MSN Mirabig Tablet ER

Mirabegron (25mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
Medical applications
The MSN Mirabig Tablet ER, containing 25mg of Mirabegron, is an extended-release oral medication primarily indicated for the treatment of overactive bladder with symptoms such as urge urinary incontinence, urgency, and frequency in adults. It works by relaxing the bladder muscles, thereby increasing the bladder capacity and reducing the urgency to urinate. The tablet's extended-release formulation allows for once-daily dosing, improving patient compliance. It should be taken orally once daily with or without food. Dosage adjustments may be necessary for patients with moderate or severe hepatic impairment. Common adverse effects include hypertension, headache, and urinary tract infection. Consult a healthcare provider for more detailed information about its use, potential interactions, and safety precautions.
Anilide Derivative
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
MSN Mirabig Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
MSN Mirabig Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
MSN Mirabig Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of MSN Mirabig Tablet ER may be needed. Please consult your doctor.
Exercise Caution
MSN Mirabig Tablet ER does not usually affect your ability to drive.
Consult Doctor
MSN Mirabig Tablet ER should be used with caution in patients with liver disease. Dose adjustment of MSN Mirabig Tablet ER may be needed. Please consult your doctor. Use of MSN Mirabig Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
0 reviews for MSN Mirabig Tablet ER















